{"blog": [], "keywords": [{"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Allergan Inc", "name": "organizations", "rank": "2", "is_major": "N"}, {"value": "Zoetis Inc", "name": "organizations", "rank": "3", "is_major": "N"}, {"value": "Ackman, William A", "name": "persons", "rank": "4", "is_major": "N"}, {"value": "Pfizer Inc", "name": "organizations", "rank": "5", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/05/11/business/dealbook/change-is-in-the-air-for-pharmaceutical-mergers.html", "document_type": "article", "byline": {"person": [{"lastname": "CYRAN", "firstname": "Robert", "role": "reported", "organization": "", "rank": 1}], "original": "By ROBERT CYRAN"}, "type_of_material": "News", "multimedia": [], "section_name": "Business Day", "word_count": "386", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "The recent actions of Zoetis and Allergan suggest a more subdued approach to deals.", "pub_date": "2016-05-11T00:00:00Z", "news_desk": "Business", "headline": {"main": "Change Is in the Air for Pharmaceutical Mergers", "content_kicker": "Breakingviews"}, "print_page": null, "snippet": "The recent actions of Zoetis and Allergan suggest a more subdued approach to deals.", "_id": "5732686338f0d83b1f371443", "slideshow_credits": null, "abstract": null}